Absence of SOP for Tracking Recurring CAPAs: A Critical GMP Oversight
Absence of SOP for Tracking Recurring CAPAs: A Critical GMP Oversight Why Not Tracking Recurring CAPAs Is a Major Compliance Weakness Introduction to the Audit Finding 1. Overview of the Issue Pharmaceutical facilities often implement Corrective and Preventive Actions (CAPAs) but fail to track recurring CAPAs due to the absence of a structured SOP. This…
Read More “Absence of SOP for Tracking Recurring CAPAs: A Critical GMP Oversight” »